AlphaFold predicted structure
KDM3B · Q7LBC6

Mean pLDDT
58.4/ 100
Low
1,761 residues
Confidence breakdown
- Very high(≥ 90)23%
- Confident(70–90)21%
- Low(50–70)5%
- Very low(< 50)51%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
lysine demethylase 3B
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
Childhood solid tumours
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedDDG2P
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownIntellectual disability
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownMonogenic hearing loss
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownMonogenic short stature
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownDiets-Jongmans syndrome
hereditary disease
Neurodevelopmental delay
syndromic intellectual disability
neurodevelopmental disorder
Rare genetic epilepsy
Rare genetic intellectual disability
pilocytic astrocytoma
autism spectrum disorder
atrial fibrillation
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Lysine-specific demethylase 3B
Histone demethylase that specifically demethylates 'Lys-9' of histone H3, thereby playing a central role in histone code. Demethylation of Lys residue generates formaldehyde and succinate. May have tumor suppressor activity
KDM3B · Q7LBC6

Mean pLDDT
58.4/ 100
Low
1,761 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0